tradingkey.logo

Rockwell Medical Inc

RMTI
1.060USD
+0.060+6.00%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
41.77MCap. mercado
PérdidaP/E TTM

Rockwell Medical Inc

1.060
+0.060+6.00%

Más Datos de Rockwell Medical Inc Compañía

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Información de Rockwell Medical Inc

Símbolo de cotizaciónRMTI
Nombre de la empresaRockwell Medical Inc
Fecha de salida a bolsaJan 27, 1998
Director ejecutivoStrobeck (Mark)
Número de empleados244
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 27
Dirección30142 Wixom Road
CiudadWIXOM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal48393
Teléfono18004493353
Sitio Webhttps://www.rockwellmed.com/
Símbolo de cotizaciónRMTI
Fecha de salida a bolsaJan 27, 1998
Director ejecutivoStrobeck (Mark)

Ejecutivos de Rockwell Medical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-6926.00%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+50000.00%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+97500.00%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-5079.00%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2868.00%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+50000.00%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
105.07K
-886.00%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Allen R. Nissenson, M.D.
Dr. Allen R. Nissenson, M.D.
Independent Director
Independent Director
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-6926.00%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+50000.00%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+97500.00%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-5079.00%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2868.00%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+50000.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Concentrate Products
15.93M
0.00%
Drug Products
0.00
0.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
13.82M
86.80%
Rest of World
2.10M
13.20%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Concentrate Products
15.93M
0.00%
Drug Products
0.00
0.00%

Estadísticas de accionistas

Actualizado: sáb., 7 de feb
Actualizado: sáb., 7 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.55%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
Otro
84.46%
Accionistas
Accionistas
Proporción
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.55%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
Otro
84.46%
Tipos de accionistas
Accionistas
Proporción
Corporation
9.03%
Investment Advisor
5.38%
Individual Investor
4.19%
Hedge Fund
1.60%
Investment Advisor/Hedge Fund
1.47%
Research Firm
0.09%
Venture Capital
0.04%
Otro
78.21%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
93
3.56M
9.03%
-3.52M
2025Q3
98
6.21M
18.04%
-1.88M
2025Q2
119
12.15M
35.56%
-1.45M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
2023Q3
122
6.04M
24.13%
+2.56M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Irrevocable Larson Family Investment Trust
3.56M
9.03%
+87.50K
+2.52%
Apr 11, 2025
The Vanguard Group, Inc.
1.35M
3.44%
+148.74K
+12.34%
Sep 30, 2025
Renaissance Technologies LLC
562.21K
1.43%
+20.45K
+3.78%
Sep 30, 2025
Geode Capital Management, L.L.C.
323.15K
0.82%
+2.48K
+0.77%
Sep 30, 2025
Strobeck (Mark)
283.69K
0.72%
-6.93K
-2.38%
Oct 01, 2025
BlackRock Institutional Trust Company, N.A.
216.09K
0.55%
-1.56K
-0.72%
Sep 30, 2025
Ravich (Mark H)
151.10K
0.38%
+50.00K
+49.45%
May 20, 2025
Radie (Robert Samuel)
143.52K
0.36%
+50.00K
+53.46%
May 20, 2025
Timmins (Megan Carden)
142.68K
0.36%
+97.50K
+215.79%
May 20, 2025
Nissenson Allen R
142.60K
0.36%
+50.00K
+54.00%
May 20, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
Proporción0.01%
Dimensional US Core Equity 1 ETF
Proporción0%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
Fecha
Fecha ex-dividendo
Tipo
Relación
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
KeyAI